CD8A and neoplasm: In an E0771-SIY tumor model, a significant increase in tumor inhibition and overall survival was observed in mice receiving α4-1BB plus ACT using SIY-specific 2C A2BR–/– CD8+ T cells compared with that using 2C WT CD8+ T cells (Figure 7B).